Event Brief
Abivax shares jump 34% after new bowel disease data
Filed: Jun 30, 2026 at 9:00 AM ET
Summary: Abivax shares rose Tuesday after the company released fresh data on its lead bowel-disease drug.
WHO: Abivax
WHAT: Abivax released fresh data on its lead drug for bowel disease, driving a 34% share price jump.
WHEN: Jun 30, 2026 at 5:28 AM ET
WHERE: France
WHY: The share move followed Abivax releasing fresh data on its lead bowel-disease medicine.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →